Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Stopping Infliximab, Methotrexate, and Azathioprine in Patients with Sarcoidosis in Remission
FranceStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
FranceStudy on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease
FranceStudy on Improving Live Birth Rates in Women Under 37 with Infertility Using cpFT During ICSI
FranceStudy of Atezolizumab Combined with Radiotherapy in Patients with Operable Soft Tissue Sarcomas
FranceStudy on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)
FranceStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer
FranceStudy on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant
FranceStudy on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib
FranceStudy on Guselkumab for Healing in Crohn's Disease Patients
FranceStudy of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer
FranceStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
